BERLIN (Reuters) – U.S.-German medical device maker Siemens Healthineers stuck with its outlook for the 2022 financial year on Wednesday as supply-chain headwinds and COVID-19 lock-downs pushed some sales into next quarters.
The company said it expected comparable revenue growth of between 5.5 and 7.5% and adjusted basic earnings per share of between 2.25 euros ($2.29) and 2.35 euros.
During the group’s third quarter, net income fell to 364 million euros from 395 million euros the previous quarter.
Adjusted earnings before interest and tax (EBIT) dropped 19% to 765 million euros on revenues of 5.19 billion euros.
($1 = 0.9820 euros)
(Writing by Rachel More, editing by Kirsti Knolle)
